JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Stocks · News reference
Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.
SemiAnalysis says AI safety could boost Nvidia GPU demand as monitoring, alignment and cybersecurity consume more compute.
Shares of CrowdStrike Holdings are edging lower Wednesday as investors await the Federal Reserve’s interest rate decision later in the day.
Rising AI safety concerns from tech leaders calling for slower AI development are expected to boost cybersecurity spending and investments. Major cybersecurity firms posted double-digit gains as investors recognize that securing AI infrastructure and protecting against AI-driven threats will remain critical priorities even as development pace moderates. Cybersecurity ETFs offer diversified exposure to this growing sector.
Major AI companies Anthropic, OpenAI, and xAI have called for a slowdown in AI development due to safety concerns. This could negatively impact hardware suppliers and cybersecurity vendors that have benefited from rapid AI expansion. AMD and CrowdStrike are identified as particularly vulnerable due to their high valuations and dependence on AI-driven demand.